To ask the Secretary of State for Health, whether he has had any discussions with the Home Secretary on the Medicines and Healthcare Products Regulatory Agency's (MHRA) review of the classification of products containing cannabidiol since the MHRA's news story on that review was published on 13 October 2016.
Answered on
28 October 2016
There have been no discussions at Ministerial level but officials from the Medicines and Healthcare products Regulatory Agency (MHRA) and the Home Office have been in contact regarding this issue.
At present, the MHRA has offered an opinion that products containing cannabidiol used for medical purposes should be regulated as medicinal products. If manufacturers do not accept this, the MHRA can use a statutory determination process to formally classify their product(s).